Europe Market Report for Ophthalmic Viscosurgical Devices 2017 – MedCore

Europe Market Report for Ophthalmic Viscosurgical Devices 2017 – MedCore

0

  • Year: 2017
  • Scope: 2013-2023
  • Region: Europe
  • Published Date: 11/28/16
  • Pages: 71
  • Type: MedCore

Ophthalmic viscosurgical devices (OVD) are viscoelastic solutions used in several eye surgeries. They are also referred to as viscoelastic agents. These fluids have had a great influence on both extracapsular and phacoemulsification surgeries and their use has decreased the incidence of corneal edema. The main task of the OVD is protecting the inner side of the cornea during surgery. It accomplishes this by maintaining a deep anterior chamber during anterior segment surgery. This space prevents contact with and possible damage to the endothelial cell layer on the inner side of the cornea and the surrounding ocular tissues. In addition OVDs help to push back the vitreous face in the event of a posterior capsule tear or a rent in the zonules all the while preventing formation of a flat chamber during surgery.

General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The OVD market is expected to grow slightly throughout the forecast period. Demand for OVDs will be driven by the aging population and the associated need for refractive correction among this demographic. OVD use is directly correlated with IOL sales. In general, growth of the IOL market is driven by the increasing prevalence of cataracts, a condition that is associated with older age. Since standard monofocal IOLs are covered by most government health insurance overall IOL insertion rates do not depend on economic stability. Because of this, procedure rates should remain constant as should OVD use.
Whether a dispersive or cohesive OVD is used depends on both physician preference and the situation; however, both are similarly priced. Combination OVDs are being produced in an attempt to provide the advantages of both cohesive and dispersive OVDs and thus simplifying the procedure. Some physicians however do not see combination OVDs as an improvement and are not willing to pay the more premium price for them. Finally some companies also package an anesthetic mixed in with their OVD to further simplify things. Again, this is another premium that some physicians find unnecessary and would prefer to anesthetize separately.
Longer life expectancy and a shift towards an older average age among the European population will lead to increased incidences of cataracts. Because cataracts can lead to blindness, the surgery is considered essential. The changing demographics of the European population will therefore lead to an increase in the overall sales of IOLs. OVDs are required for IOL insertion surgeries and thus their sales will increase accordingly.



The "European Market Report Suite for Diagnostic and Interventional Ophthalmic Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Alcon
AMO
Carl Zeiss Meditec
Bausch & Lomb
STAAR Surgical
Topcon
Haag-Streit
Oculus
Heidelberg Engineering
CSO
Nidek
Hoya
Bon Optic
Ziemer
Optovue
PhysIOL
Oertli
Quantel
Canon
Sonomed
CenterVue
Kowa
Accutome
Reichert
Tomey
Keeler
iCare
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Sign Up

Already have an account? Sign in

×